Skip to content

Clinical trials

Phase 3 Schizophrenia trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 3 Country / region: Bulgaria Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20051
20073
20085
20105
20111
20123
20133
20151
20164
20173
20182
20195
20201
20214
20222
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Terminated7
Recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.9
Alkermes, Inc.6
AstraZeneca4
ACADIA Pharmaceuticals Inc.3
H. Lundbeck A/S3
Janssen Research & Development, LLC3
Janssen-Cilag International NV3
Karuna Therapeutics, Inc., a Bristol Myers Squibb company3
Neurocrine Biosciences3
Boehringer Ingelheim2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia50
Psychotic Disorders3
Autistic Disorder1
Bipolar Disorder1
Mania1
Recurrence1

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.